Vanguards of Healthcare: Tandem’s Next Wave of Insulin Pump Tech
“If you look at the tubeless market, we’re seeing growth rates in excess of 25% annually,” Tandem Diabetes CEO John Sheridan tells Bloomberg Intelligence about the growth in insulin pumps....
By Aditya Somani · Bloomberg
“If you look at the tubeless market, we’re seeing growth rates in excess of 25% annually,” Tandem Diabetes CEO John Sheridan tells Bloomberg Intelligence about the growth in insulin pumps. In this episode of the Vanguards of Healthcare podcast, Sheridan sits down with BI analyst Matt Henriksson for an in-depth interview about Tandem’s upcoming launch of Mobi Tubeless, an insulin pump designed to be worn discreetly on the body, and the AI-powered Control-IQ Plus algorithm for simplicity. The conv